Study of serious adverse drug reactions using FDA-approved drug labeling and MedDRA.

Name: Study of serious adverse drug reactions using FDA-approved drug labeling and MedDRA.
Author: Wu, Leihong

Study of serious adverse drug reactions using FDA-approved drug labeling and MedDRA. — المؤلف: Wu, Leihong — BMC bioinformatics 20190502

المؤلف: Wu, Leihong
النشر: BMC bioinformatics 20190502
الوصف: 97 p.
الموضوعات: Adverse Drug Reaction Reporting Systems؛ Data Mining؛ Drug Labeling؛ Drug-Related Side Effects and Adverse Reactions؛ Humans